RIGL: Rigel Pharmaceuticals, Inc.

Biotechnology (Health Care)

View latest RIGL posts below

 
 
RIGL on Covestor
Today
Members Holding: 4
Top Rated Rationale
No votes.
 
Most held in the same sector
PFE, JNJ, MRK, AMGN
 
 

Top 10 Members Holding

 

Best Covestor performers in this stock.

Rank
MemberSharpe RatioAnn. ReturnRisk (SD)Exposure
1
lukehappy [100] Star!Star! 1.14 50.01% Medium (39.49%)
Short  
2
streetspirit [31] Star! -0.23 -62.65% HIgh (295.42%) Not currently holding
3
doubledown [19] Star!Star! -0.26 -4.79% Medium (37.78%) Not currently holding
4
ejw060412 [18] Star! -0.64 -41.25% HIgh (72.44%) Not currently holding
5
jhains2 [216] -0.81 -29.21% Medium (41.98%) Not currently holding
6
Matsposta [164] -0.84 -54.61% HIgh (71.19%) Not currently holding
7
therealhoff [0] -1.01 -77.84% HIgh (82.37%) Not currently holding
8
EquityStar [0] -1.14 -43.14% Medium (42.29%)
  Long
9
Matt [0] -1.20 -54.46% HIgh (49.47%) Not currently holding
10
felixlo [55] -1.28 -59.21% HIgh (50.16%)
  Long

* Inclusion in this ranking requires a minimum 2 months Covestor membership.

RIGL - Sell - We got two immediate up closes in RIGL after we bought 2/7, and a nice pop this morning at... More

Posted by tmantrader on 11-Feb-08 08:03    

RIGL - Buy - RIGL is a niche pharmaceutical play specializing in the area of inflammatory/autoimmu... More

Posted by tmantrader on 07-Feb-08 13:27    

Due Diligence MIA - Well, I haven't done much DD here on the fundies, but I'm trading the chart pattern/breako... More

Posted by jhains2 on 28-Dec-07 07:39    

Paging Due Diligence, Paging Due Diligence - Bought a tiny position in order to force myself to do some due diligence. A pill-based tre... More

Posted by jhains2 on 19-Dec-07 15:14    

Latest Activity in RIGL

1
dummystocks Sold 23.71
2
bioinvest Sold 21.91
3
bioinvest Sold 21.91
4
lukehappy Bought 22.99
5
lukehappy Bought 21.25
6
lukehappy Bought 21.51
7
lukehappy Bought 21.51
8
lukehappy Bought 21.51
9
lukehappy Bought 21.51
10
lukehappy Bought 22.29

Latest RIGL Headlines

Health Winners & Losers: Cell Ge...